Description
Breaking boundaries: Innovating the future of hepatitis B and D treatment together
Faculty
- Thomas Berg (Moderator)
- Larry Blatt (Aligos representative)
- Todd Correll (VIR representative)
- Susan Dixon (GSK representative)
- Simon Fletcher (Gilead representative)
This EASL Studio is supported by Aligos Therapeutics, Gilead, GSK and VIR Biotechnology.
ℹ️ Please click here to watch this EASL Studio episode.